Kim Ha Youn, Kim Sung Tae, Kim Hyung-Jin, Jeon Pyoung, Byun Hong Sik, Kim Yi Kyung, Cha Jihoon, Park Gyeong Min, Nam Do-Hyun, Kong Doo-Sik
Department of Radiology, Eulji University Hospital, Daejeon.
Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine.
Medicine (Baltimore). 2019 Jul;98(27):e16089. doi: 10.1097/MD.0000000000016089.
To establish magnetic resonance imaging (MRI) features that differentiate residual tumors from postoperative surgical changes following the transsphenoidal approach of a pituitary adenoma.We analyzed residual enhancements at the tumor bed in 52 patients who underwent dynamic contrast-enhanced sella MRI within 48 hours after surgery and at 6 to 28 months. Patients were divided into 2 groups defined by either peripheral or nodular enhancement patterns. For each group, we measured the maximum thickness of the residual enhancing portion and compared differences in the residual tumor and postoperative changes.Among the tumors examined in the 52 patients, 19 residual tumors showed nodular (n = 16) and peripheral (n = 3) enhancement patterns, and 33 postoperative changes showed nodular (n = 3) and peripheral (n = 30) enhancement patterns. The mean residual tumor thickness was 7.1 mm (range, 2.9-16.8 mm) and 1.9 mm (range, 1.0-7.4 mm) in the postoperative change. Receiver operating characteristic curve analysis revealed that a 3.9-mm thickness was associated with 89% sensitivity, 97% specificity, and 94% accuracy for diagnosis of residual tumor.On immediate postoperative MRI, residual enhancement with greater than 3.9-mm thickness and nodular pattern suggest residual pituitary adenoma tumor.
为确定垂体腺瘤经蝶窦入路术后区分残留肿瘤与手术改变的磁共振成像(MRI)特征。我们分析了52例患者肿瘤床的残留强化情况,这些患者在术后48小时内及术后6至28个月接受了动态对比增强鞍区MRI检查。患者根据外周或结节状强化模式分为两组。对于每组,我们测量了残留强化部分的最大厚度,并比较了残留肿瘤与术后改变的差异。在52例患者检查的肿瘤中,19例残留肿瘤表现为结节状(n = 16)和外周(n = 3)强化模式,33例术后改变表现为结节状(n = 3)和外周(n = 30)强化模式。残留肿瘤的平均厚度为7.1mm(范围2.9 - 16.8mm),术后改变的平均厚度为1.9mm(范围1.0 - 7.4mm)。受试者工作特征曲线分析显示,厚度3.9mm对残留肿瘤诊断的敏感性为89%,特异性为97%,准确性为94%。术后即刻MRI上,厚度大于3.9mm且呈结节状模式的残留强化提示残留垂体腺瘤肿瘤。